Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Filters: 0    Descriptive       Fundamental       Technical       All   
Exchange Index Sector Industry Country
Market Cap. Dividend Yield Float Short Analyst Recom. Option/Short
Earnings Date Average Volume Relative Volume Current Volume Price
 
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 9 #1
TickerAVNW [NASD]
CompanyAviat Networks, Inc.
CountryUSA
IndustryCommunication Equipment
Market Cap112.46MEPS (ttm)-0.83
P/E-EPS this Y-361.10%
Forward P/E-EPS next Y90.00%
PEG-EPS past 5Y32.50%
P/S0.32EPS next 5Y12.00%
P/B1.08EPS Q/Q-233.30%
Dividend-Sales Q/Q-21.20%
Insider Own0.40%Inst Own70.20%
Insider Trans-Inst Trans9.07%
Short Float2.21%EarningsOct 28/a
Analyst Recom2.00Target Price2.15
Avg Volume381.01K52W Range0.99 - 2.81
22-Oct-14 09:00AMAviat Wins IP/MPLS Business with Newly Released CTR 8611 PR Newswire
10-Oct-14 09:27AMAviat (AVNW) is in Overbought Territory: What's Next? Zacks
07-Oct-14 09:00AMAviat Networks Acknowledges Receipt of Director Nominations PR Newswire
30-Sep-14 12:39PMAVIAT NETWORKS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa EDGAR Online
30-Sep-14 09:00AMAviat Networks Receives Expected NASDAQ Notice Related to Delay in Form 10-K Filing PR Newswire
15-Sep-14 04:05PMAviat Networks to Present at the Singular Research Conference PR Newswire
11-Sep-14 09:14AMAviat (AVNW) Enters Overbought Territory Zacks
10-Sep-14 09:00AMBATS Wireless and Aviat Networks form High-Capacity Wireless Broadband Solutions Partnership for the Energy Market PR Newswire
09-Sep-14 09:00AMHeavy Reading-Aviat Networks Survey: Mobile Operators See Fixed Enterprise Services As Strategic PR Newswire
05-Sep-14 07:19AMCoverage initiated on Aviat Networks by H.C. Wainwright Briefing.com
Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services in North America and Internationally. It offers point-to-point digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. The company's products include network management software solutions to enable operators to deploy, monitor, and manage its systems, as well as third party equipment, such as antennas, routers, and multiplexers to build and deploy a wireless transmission network and a suite of turnkey support services. It also provides broadband wireless access base stations and customer premises equipment for fixed and mobile; point-to-point digital microwave radio systems for access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. In addition, the company offers various professional services, such as network planning and design, site surveys and builds, systems integration, installation, maintenance, network monitoring, training, and customer services. It serves wireless/mobile service providers, original equipment manufacturers, distributors, and system integrators; and private network users, such as public safety agencies and government institutions; and utility, pipeline, railroad, and other industrial enterprises that operate broadband wireless networks. The company was formerly known as Harris Stratex Networks, Inc. and changed its name to Aviat Networks, Inc. in January 2010. Aviat Networks, Inc. is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stumpe HeinzSVP & Chief Sales OfficerSep 09Sale1.532,4013,674116,980Sep 10 02:18 PM
Elliott Meena L.SVP, Gen. Counsel & SecretarySep 09Sale1.531,5842,42499,632Sep 10 02:19 PM
Madigan JohnVP, Corporate Controller & PAOSep 09Sale1.531,0051,53851,829Sep 10 02:17 PM
Stumpe HeinzSVP & Chief Sales OfficerJun 30Sale1.205,4926,593119,381Jul 01 12:36 PM
Elliott Meena L.SVP, Gen. Counsel & SecretaryJun 30Sale1.202,9063,488101,216Jul 01 12:35 PM
TickerDYAX [NASD]
CompanyDyax Corp.
CountryUSA
IndustryBiotechnology
Market Cap1.47BEPS (ttm)-0.14
P/E-EPS this Y13.30%
Forward P/E-EPS next Y31.60%
PEG-EPS past 5Y24.80%
P/S22.90EPS next 5Y18.60%
P/B14.22EPS Q/Q75.00%
Dividend-Sales Q/Q73.50%
Insider Own0.10%Inst Own96.70%
Insider Trans-42.09%Inst Trans0.99%
Short Float5.83%EarningsOct 28
Analyst Recom1.70Target Price12.36
Avg Volume967.46K52W Range6.05 - 11.01
14-Oct-14 08:00AMDyax Corp. to Host Third Quarter 2014 Earnings Call and Webcast Business Wire
25-Sep-14 07:00AMDyax Corp. to Participate in the Leerink Partners Rare Disease Roundtable Business Wire
23-Sep-14 07:57AMDYAX CORP Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
22-Sep-14 07:12AMDyax Corp. Highlights Recent Progress in Licensing and Funded Research Portfolio Business Wire
15-Sep-14 07:00AMDyax Corp. Announces Issuance of Two Key U.S. Patents for DX-2930 Business Wire
08-Aug-14 01:04PMDYAX CORP Financials EDGAR Online Financials
01-Aug-14 05:27PMDYAX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
29-Jul-14 04:56PMDYAX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
29-Jul-14 04:01PMDyax Corp. Announces Second Quarter 2014 Financial Results Business Wire
29-Jul-14 07:07AMQ2 2014 Dyax Corp. Earnings Release - Time Not Supplied CCBN
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. The company offers KALBITOR for the treatment of acute attacks of HAE. It is developing DX-2930, a human monoclonal antibody inhibitor of plasma kallikrein, which would be a candidate to prophylactically treat HAE and other PKM disorders. The company distributes KALBITOR through a network of wholesale and specialty pharmacy arrangements. It has agreements with CVie Therapeutics for the development and commercialization of KALBITOR in the treatment of HAE and other angioedema indications in China; and Novellus Biopharma AG for the development and commercialization of KALBITOR for the treatment of HAE and other angioedema indications in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico, and Venezuela. The company also has a strategic collaboration agreement with Sigma-Tau Rare Diseases S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia. Dyax Corp. was founded in 1989 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KEMPNER THOMAS LDirectorSep 12Sale11.004,90053,900717,120Sep 15 04:29 PM
KEMPNER THOMAS LDirectorSep 11Sale11.007,50082,500722,020Sep 15 04:29 PM
KEMPNER THOMAS LDirectorAug 26Sale10.3937,000384,486729,520Aug 27 04:28 PM
KEMPNER THOMAS LDirectorAug 07Sale9.2533,190306,95449,264Aug 11 04:49 PM
MIGAUSKY GEORGE VEVP & Chief Financial OfficerJun 13Sale8.256,00049,50224,000Jun 17 04:10 PM
TickerKOS [NYSE]
CompanyKosmos Energy Ltd.
CountryBermuda
IndustryIndependent Oil & Gas
Market Cap3.56BEPS (ttm)0.23
P/E40.00EPS this Y-33.30%
Forward P/E25.84EPS next Y24.91%
PEG1.75EPS past 5Y-4.80%
P/S3.66EPS next 5Y22.85%
P/B3.03EPS Q/Q215.40%
Dividend-Sales Q/Q-22.00%
Insider Own4.50%Inst Own53.60%
Insider Trans-11.77%Inst Trans4.79%
Short Float1.91%EarningsNov 03/b
Analyst Recom2.30Target Price13.83
Avg Volume1.72M52W Range8.32 - 11.60
21-Oct-14 09:54AMKosmos Energy upgraded by Global Hunter Securities Briefing.com
17-Oct-14 05:59AMKOSMOS ENERGY LTD. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial EDGAR Online
16-Oct-14 06:00PMThomas P. Chambers Joins Kosmos as Chief Financial Officer Business Wire
10-Oct-14 04:01PMKosmos Energy Announces Closing of Secondary Public Offering of Common Shares Business Wire
10-Oct-14 09:33AMKOSMOS ENERGY LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online
07-Oct-14 12:24PMWhy Kosmos Energy (KOS) Stock Is Falling Today at TheStreet
06-Oct-14 04:30PMKosmos Energy Announces Secondary Public Offering of Common Shares Business Wire
04-Oct-14 03:39PMKosmos to buy into Senegal offshore blocks for $400 mln - Petrosen draft Reuters
04-Oct-14 02:41PMSenegalese Petrosen set to sign $400 mln offshore deal -document Reuters
01-Oct-14 05:07PMKOSMOS ENERGY LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan EDGAR Online
Kosmos Energy Ltd. explores and produces oil and gas in Africa, Europe, and South America. Its asset portfolio includes production and other projects offshore Ghana, as well as exploration licenses with hydrocarbon potential offshore Ireland, Mauritania, Morocco, and Suriname. The company was founded in 2003 and is based in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BCP IV GP L.L.C.10% OwnerOct 10Sale9.336,749,99562,977,453270,001Oct 10 05:36 PM
Blackstone Holdings III L.P.10% OwnerOct 10Sale9.336,750,00062,977,500270,001Oct 10 05:35 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.337,951,43774,186,90756,556,832Oct 15 01:50 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.3316,500,000153,945,000118,008,651Oct 15 01:50 PM
Krieger David BenjaminDirectorOct 10Sale9.338,250,00076,972,500118,008,651Oct 15 01:54 PM
TickerMHLD [NASD]
CompanyMaiden Holdings, Ltd.
CountryBermuda
IndustryProperty & Casualty Insurance
Market Cap881.85MEPS (ttm)0.83
P/E14.58EPS this Y79.70%
Forward P/E6.80EPS next Y20.27%
PEG1.21EPS past 5Y29.20%
P/S0.41EPS next 5Y12.00%
P/B0.98EPS Q/Q-44.30%
Dividend3.64%Sales Q/Q-46.60%
Insider Own0.60%Inst Own70.10%
Insider Trans7.37%Inst Trans-0.07%
Short Float5.71%EarningsNov 04/a
Analyst Recom1.40Target Price15.00
Avg Volume263.26K52W Range9.97 - 13.11
24-Oct-14 08:30AMMaiden Holdings, Ltd. to Release Third Quarter 2014 Earnings on November 5, 2014 and Host Conference Call on November 6, 2014 GlobeNewswire
23-Sep-14 08:30AMMaiden Holdings to Present at the JMP Securities Financial Services & Real Estate Conference on September 30, 2014 GlobeNewswire
29-Aug-14 10:00AMMaiden Holdings to Present at the Keefe, Bruyette & Woods Insurance Conference on September 4, 2014 GlobeNewswire
19-Aug-14 01:04PMMAIDEN HOLDINGS, LTD. Financials EDGAR Online Financials
11-Aug-14 04:09PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
11-Aug-14 03:52PMMAIDEN HOLDINGS, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online
08-Aug-14 08:53AMCompass Point Believes Premium Growth And Loss Ratio Support Thesis For Maiden Benzinga
07-Aug-14 09:30AMMaiden Holdings (MHLD) Q2 Earnings in Line, Revenues Beat Zacks
06-Aug-14 05:24PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
06-Aug-14 04:35PMMaiden Holdings, Ltd. Announces Record Quarterly Net Operating Earnings(1) of $28.2 Million or $0.37 Per Diluted Common Share and Operating Return on Common Equity(1) of 13.0% GlobeNewswire
Maiden Holdings, Ltd., together with its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. The company operates through three segments: Diversified Reinsurance, AmTrust Quota Share Reinsurance, and NGHC Quota Share. The Diversified Reinsurance segment offers property, casualty, accident, and health reinsurance products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis primarily through third-party intermediaries and on a direct basis. The AmTrust Quota Share Reinsurance segment provides small commercial business insurance, which includes workers' compensation, commercial package, and other property and casualty insurance products; specialty risk and extended warranty coverage for consumer and commercial goods, as well as custom designed coverage, including accidental damage plans and payment protection plans in connection with the sale of consumer and commercial goods; and specialty program that comprises package products, general liability, commercial auto liability, excess and surplus lines programs, and other specialty commercial property and casualty insurance to small and middle market companies. The NGHC Quota Share segment reinsures personal lines automobile business under the quota share reinsurance agreement. The company also offers credit life reinsurance. The company was founded in 2007 and is headquartered in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHMITT KARENChief Financial OfficerSep 03Option Exercise4.0024,17596,610111,324Sep 03 04:03 PM
NEFF RAYMOND MICHAELDirectorMar 27Option Exercise0.0024,0000249,000Mar 28 06:55 AM
MARSHALECK JOHNCHIEF FINANCIAL OFFICERMar 21Option Exercise3.2825,00082,00079,730Mar 24 05:04 PM
RASCHBAUM ARTURO MANUELPRESIDENT AND CEOFeb 18Option Exercise0.00136,6050270,892Feb 20 04:20 PM
TickerMR [NYSE]
CompanyMindray Medical International Limited
CountryChina
IndustryMedical Instruments & Supplies
Market Cap3.47BEPS (ttm)1.69
P/E17.34EPS this Y24.70%
Forward P/E14.39EPS next Y12.42%
PEG4.84EPS past 5Y14.30%
P/S2.74EPS next 5Y3.58%
P/B2.32EPS Q/Q-3.80%
Dividend1.71%Sales Q/Q8.90%
Insider Own0.43%Inst Own81.70%
Insider Trans-Inst Trans-0.11%
Short Float18.15%EarningsNov 03/a
Analyst Recom2.40Target Price34.50
Avg Volume485.19K52W Range28.43 - 41.46
15-Oct-14 08:00AMMindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs PR Newswire
14-Oct-14 08:00AMMindray to Report Third Quarter 2014 Financial Results on Nov 3, 2014 PR Newswire
24-Sep-14 08:13AMThe Zacks Analyst Blog Highlights: Yingli Green Energy Holding, JD.com, Mindray Medical International, Signet Jewelers and Tiffany Zacks
17-Sep-14 07:47PMTop Foreign Stock Funds at Investor's Business Daily
17-Sep-14 05:00AMQuality Exams at Your Fingertips PR Newswire
09-Sep-14 12:30PMMindray Medical Down to Strong Sell on Weak Q2 Zacks
18-Aug-14 09:30PMAsia Morning Read: Solar Module Shortage, Chinese Hackers at Barrons.com
15-Aug-14 08:01AMThe Zacks Analyst Blog Highlights: ReneSola, eLong, China Unicom Hong Kong, Mindray Medical International and Bitauto Holdings Zacks
12-Aug-14 10:00AMMindray Medical Beats Q2 Earnings by a Penny, Cuts 2014 View Zacks
12-Aug-14 08:00AMMindray Medical International Ltd Earnings Call scheduled for 8:00 am ET today CCBN
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. Its markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People's Republic of China.
TickerRJET [NASD]
CompanyRepublic Airways Holdings Inc.
CountryUSA
IndustryRegional Airlines
Market Cap576.04MEPS (ttm)1.06
P/E10.88EPS this Y46.00%
Forward P/E8.22EPS next Y5.17%
PEG0.84EPS past 5Y-17.60%
P/S0.42EPS next 5Y13.00%
P/B0.98EPS Q/Q25.80%
Dividend-Sales Q/Q1.90%
Insider Own1.70%Inst Own84.40%
Insider Trans10.69%Inst Trans1.85%
Short Float4.36%EarningsNov 05
Analyst Recom2.30Target Price14.00
Avg Volume540.23K52W Range7.82 - 12.64
24-Oct-14 01:13PMAirlines shake off travel fears; gains on earnings at CNBC
22-Oct-14 08:00AMAmerican Airlines Group Inc. (AAL) Jumps: Stock Rises 7.5% Zacks
21-Oct-14 04:49PMRepublic Airways Announces Conference Call to Discuss Third Quarter 2014 Financial Results Business Wire
16-Oct-14 04:58PMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Other Events EDGAR Online
15-Oct-14 12:53PMAirline stocks lose altitude on fresh Ebola fears at Fortune
15-Oct-14 11:52AMAirline Stocks Are Rolling Over Business Insider
07-Oct-14 05:10PMRepublic Airways Holdings Reports September 2014 Traffic Business Wire
03-Oct-14 05:16PMAmerican Airlines regional operator to cut about 50 jobs in Miami Reuters
03-Oct-14 04:33PMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Other Events EDGAR Online
22-Sep-14 05:17PMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online
Republic Airways Holdings Inc., through its subsidiaries, provides scheduled passenger services. It offers scheduled passenger service on approximately 1,390 flights daily to approximately 118 cities in the U.S. and Canada through fixed-fee flights operated under airline partner brands, including American Eagle, Delta Connection, United Express, and US Airways Express. As of December 31, 2013, the company operated a combined fleet of approximately 258 aircraft. It is also engaged in charter and cargo operations. The company was founded in 1996 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dooley Timothy P.EVP, CFO, Treasurer, SecretarySep 18Sale11.573,00034,71060,000Sep 19 05:06 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretarySep 17Option Exercise6.323,60022,75266,600Sep 19 05:06 PM
Arnell Lars ErikSVP Corporate DevelopmentSep 17Option Exercise6.323,30020,85658,300Sep 19 05:03 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretarySep 17Sale11.323,60040,75263,000Sep 19 05:06 PM
Arnell Lars ErikSVP Corporate DevelopmentSep 17Sale11.323,30037,35655,000Sep 19 05:03 PM
TickerSGMO [NASD]
CompanySangamo Biosciences Inc.
CountryUSA
IndustryBiotechnology
Market Cap773.73MEPS (ttm)-0.47
P/E-EPS this Y-14.30%
Forward P/E-EPS next Y-29.00%
PEG-EPS past 5Y4.40%
P/S24.88EPS next 5Y-
P/B3.60EPS Q/Q0.00%
Dividend-Sales Q/Q50.70%
Insider Own1.40%Inst Own76.60%
Insider Trans-6.19%Inst Trans0.52%
Short Float15.98%EarningsOct 22/a
Analyst Recom1.70Target Price25.40
Avg Volume865.52K52W Range8.93 - 24.69
22-Oct-14 06:16PMSangamo tops Street 3Q forecasts AP
22-Oct-14 05:00PMSangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today CCBN
22-Oct-14 04:31PMSANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
22-Oct-14 04:02PMSangamo BioSciences Reports Third Quarter 2014 Financial Results PR Newswire
22-Oct-14 07:07AMQ3 2014 Sangamo BioSciences Inc Earnings Release - After Market Close CCBN
20-Oct-14 11:50AMWill Sangamo (SGMO) Incur Wider-than-Expected Q3 Loss? Zacks
16-Oct-14 07:00AMSangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014 PR Newswire
15-Oct-14 04:02PMSangamo BioSciences Announces Third Quarter 2014 Conference Call and Webcast PR Newswire
24-Sep-14 06:58AMSangamo Biosciences (SGMO) Jumps: Stock Rises 5.4% Zacks
15-Sep-14 10:30AMInsider Trading Alert - SPR, RTN And SGMO Traded By Insiders at TheStreet
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company's principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. It also develops CERE-110 that is in Phase II clinical trial for the treatment of Alzheimer's disease. In addition, the company has ZFP therapeutic pre-clinical stage programs for hemophilia A and B, huntington's disease, and hemoglobinopathies; and proprietary programs in the areas of lysosomal storage disorders. Further, it has ZFP therapeutic research stage programs in the areas of other monogenic diseases, including various immunodeficiencies, as well as central nervous system disorders and cancer immunotherapy. The company has collaboration and license agreements with Shire International GmbH and Biogen Idec Inc.; and strategic partnerships with Sigma-Aldrich Corporation, Dow AgroSciences, LLC, Open Monoclonal Technology, Inc., F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wolff Henry WardExec VP & CFOOct 10Sale10.102,00020,200214,347Oct 14 08:00 PM
ANDO DALE GVP, Therapeutic Dev. & CMOOct 06Option Exercise4.1115,00061,650111,579Oct 08 08:00 PM
ANDO DALE GVP, Therapeutic Dev. & CMOOct 06Sale10.7215,000160,86596,579Oct 08 08:00 PM
Gregory Philip DSVP of Research & CSOOct 01Option Exercise5.6615,00084,840124,347Oct 03 08:00 PM
Gregory Philip DSVP of Research & CSOOct 01Sale10.8015,000162,029109,347Oct 03 08:00 PM
TickerSOL [NYSE]
CompanyReneSola Ltd.
CountryChina
IndustrySemiconductor - Specialized
Market Cap248.49MEPS (ttm)-2.36
P/E-EPS this Y-1.10%
Forward P/E8.36EPS next Y1550.00%
PEG-EPS past 5Y-27.00%
P/S0.15EPS next 5Y15.00%
P/B1.57EPS Q/Q104.20%
Dividend-Sales Q/Q2.60%
Insider Own55.27%Inst Own15.90%
Insider Trans-Inst Trans-0.25%
Short Float13.25%EarningsDec 05/b
Analyst Recom3.50Target Price3.00
Avg Volume1.82M52W Range2.09 - 5.23
29-Sep-14 11:30AMReneSola's PV Testing Laboratory Joins Intertek's Global SATELLITE Program Business Wire
29-Sep-14 10:07AMSasol Limited: Appointment of Executive Director and Chief Financial Officer PR Newswire
23-Sep-14 08:24AMReneSola Launches Best-In-Class Residential Loan Program With Admirals Bank PR Newswire
18-Sep-14 04:20PMReneSola (SOL) to Supply SolarMax Inverters in Australia Zacks
17-Sep-14 03:56AMReneSola Expands Distribution Partnership with SolarMax PR Newswire
12-Sep-14 04:00PMReneSola to Provide 10-MW Solar Modules to Indian Firm Zacks
11-Sep-14 05:22AMChinas ReneSola Supplying Solar Panels for India Power Project at Bloomberg
11-Sep-14 05:00AMReneSola to Supply 10MW DCR Solar Modules to Utility-Scale Project in India PR Newswire
08-Sep-14 11:33AMWhy ReneSola (SOL) Stock Is Rising Today at TheStreet
08-Sep-14 09:40AMWill ReneSola (SOL) Continue to Surge Higher? Zacks
ReneSola Ltd, through its subsidiaries, manufactures and sells various solar power products. It operates through two segments, Wafer, and Cell and Module. The company offers virgin polysilicon; mono crystalline and multi crystalline solar wafers; and photovoltaic cells. It also provides mono crystalline and multi crystalline solar modules for use in various residential, commercial, industrial, and other solar power generation systems. In addition, the company offers wafer processing services. It offers its products to the manufacturers of solar cells and modules, distributors, installers, and end users of solar modules. The company operates in Mainland China, Taiwan, Australia, Singapore, Korea, India, Hong Kong, Japan, Germany, Greece, Belgium, Italy, France, the United States, Spain, Czech Republic, England, the Netherlands, and South Africa. ReneSola Ltd was founded in 2005 and is based in Jiashan, the People's Republic of China.
TickerSPWR [NASD]
CompanySunPower Corporation
CountryUSA
IndustrySemiconductor - Specialized
Market Cap4.10BEPS (ttm)1.39
P/E22.49EPS this Y122.90%
Forward P/E18.16EPS next Y33.10%
PEG0.75EPS past 5Y19.60%
P/S1.64EPS next 5Y30.00%
P/B3.01EPS Q/Q-40.00%
Dividend-Sales Q/Q-11.90%
Insider Own0.30%Inst Own36.90%
Insider Trans-46.94%Inst Trans1.07%
Short Float20.23%EarningsOct 29/b
Analyst Recom2.20Target Price40.57
Avg Volume2.02M52W Range25.38 - 42.07
24-Oct-14 04:56PMWhat to expect from SunPower earnings at MarketWatch
23-Oct-14 05:18PMSUNPOWER CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati EDGAR Online
21-Oct-14 06:01PMYour first trade for Wednesday at CNBC
16-Oct-14 04:45PMSunPower Announces its Advancements in Resource Conservation and Environmental Stewardship in Latest Sustainability Report PR Newswire
14-Oct-14 04:50PMSunPower (SPWR) to Supply Solar Panels for French Projects Zacks
14-Oct-14 08:00AMUPDATE: SunPower Changes Time of Third-Quarter 2013 Results Conference Call to 5:30 a.m. Pacific Time on Oct. 29, 2014 PR Newswire
13-Oct-14 10:48AMSunPower Supplying 41 Megawatts of Panels for Projects in France at Bloomberg
13-Oct-14 03:05AMSunPower Supplying 41 Megawatts of High Efficiency Solar Panels for Four La Compagnie du Vent Solar Power Plants PR Newswire
09-Oct-14 05:47AMRange-bound trades in SunPower optionMONSTER
07-Oct-14 05:04PMSunPower to Announce Third-Quarter Results on Oct. 29, 2014 PR Newswire
SunPower Corporation, an energy services company, designs, manufactures, and delivers solar systems to residential, commercial, and utility customers. It operates in three segments: the Americas, the EMEA, and the APAC. The company offers solar power products, including panels, balance of system components, and inverters. It also designs, manufactures, and sells high-performance rooftop and ground-mounted solar power systems, as well as utility-scale photovoltaic power plants. In addition, the company offers operations and maintenance services, including remote monitoring, preventative, and corrective maintenance services, as well as rapid-response outage restoration and inverter repair services. Further, it leases solar power systems to residential customers. The company serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. SunPower Corporation was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activits USA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NEESE MARTY TChief Operating OfficerOct 10Sale28.29122,3363,461,36526,441Oct 10 04:14 PM
NEESE MARTY TChief Operating OfficerOct 09Sale29.7664,3111,913,850148,777Oct 10 04:14 PM
NEESE MARTY TChief Operating OfficerOct 08Sale30.4337,0161,126,401213,088Oct 10 04:14 PM
Wenger HowardPresident, Business UnitsOct 07Sale32.0622,000705,320135,849Oct 09 04:21 PM
Branderiz EricSVP & Prin Acct OffSep 17Sale37.271,59459,4080Sep 19 05:21 PM
1